
Capitalmind Flexi Cap Fund Direct-Growth
Equity: Flexi Cap - Growth (Open ended)Download Report
SEBI Riskometer: Very HighCategory: Equity: Flexi CapBenchmark: NIFTY 500 Total Return IndexCheck Portfolio Overlap →
NAV: ₹10.64+0.44%
20 Nov 2026
Holdings Analysis
Equity, debt and cash allocation snapshot with market cap distribution for Capitalmind Flexi Cap Fund Direct-Growth.
Market Cap Distribution
Large Cap (13.2%)
Mid Cap (42.3%)
Small Cap (44.5%)
Historical Asset Allocation
| Asset | 31 Oct 2026 | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 |
|---|---|---|---|---|---|---|
| Equity | 99.30% | 96.02% | 98.86% | 98.76% | 92.91% | 91.92% |
| Debt | 1.00% | 4.24% | 1.25% | 1.30% | 4.81% | 5.97% |
| Others (incl. cash) | -0.30% | -0.26% | -0.11% | -0.06% | 0.06% | -0.12% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 2.22% | 2.23% |
Portfolio Snapshot
No. of Securities
32
P/E Ratio
22.54
P/B Ratio
3.03
Top Holding %
5.34%
Top 5 Holdings %
21.61%
Top 10 Holdings %
39.17%
AUM
₹465 Cr
Expense Ratio
1.76%
Since Inception
4.92%
Max Drawdown
-0.10%
Top Portfolio Holdings by Weight
Latest portfolio holdings sorted by allocation weight. Includes instrument name, sector, number of shares, market value (₹ Cr) and percentage of net assets. Switch dates or categories using the controls below.
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Laurus Labs Ltd. | Healthcare | 1,03,131 | 24.81 | 5.34% | 0.92%↑ |
| Bank of Maharashtra | Financial | 23,86,974 | 19.42 | 4.18% | 0.39%↑ |
| Divis Laboratories Ltd. | Healthcare | 19,402 | 18.98 | 4.08% | 0.18%↑ |
| Karur Vysya Bank Ltd. | Financial | 5,26,207 | 18.74 | 4.03% | 0.70%↑ |
| The Federal Bank Ltd. | Financial | 5,43,714 | 18.47 | 3.98% | 0.33%↑ |
| Anand Rathi Wealth Ltd. | Financial | 75,521 | 17.01 | 3.66% | 0.38%↑ |
| Granules India Ltd. | Healthcare | 1,97,271 | 16.57 | 3.57% | 0.37%↑ |
| Multi Commodity Exchange Of India Ltd. | Services | 50,454 | 16.09 | 3.46% | 0.18%↑ |
| Aurobindo Pharma Ltd. | Healthcare | 95,656 | 16.08 | 3.46% | 0.51%↑ |
| Shyam Metalics And Energy Ltd. | Metals & Mining | 1,36,180 | 15.84 | 3.41% | - |
| Sona BLW Precision Forgings Ltd. | Automobile | 1,77,494 | 15.81 | 3.40% | 0.35%↑ |
| FSN E-Commerce Ventures Ltd. | Services | 4,26,289 | 14.89 | 3.21% | 0.32%↑ |
| Dr. Lal Pathlabs Ltd. | Healthcare | 76,714 | 14.62 | 3.15% | - |
| The Great Eastern Shipping Company Ltd. | Energy | 91,182 | 14.53 | 3.13% | - |
| PVR Inox Ltd. | Services | 97,411 | 14.56 | 3.13% | - |
| Ipca Laboratories Ltd. | Healthcare | 74,839 | 14.43 | 3.11% | - |
| Zydus Lifesciences Ltd. | Healthcare | 1,14,848 | 14.3 | 3.08% | 0.32%↑ |
| Sai Life Sciences Ltd. | Healthcare | 91,527 | 14.26 | 3.07% | 0.05%↑ |
| Kotak Mahindra Bank Ltd. | Financial | 3,07,911 | 14.21 | 3.06% | - |
| Bosch Ltd. | Automobile | 2,997 | 14.15 | 3.04% | -0.02%↓ |
1 / 2
Sector-wise Portfolio Allocation
Equity exposure by sector as a percentage of total net assets, tracked across recent portfolio dates. Identifies concentration risk and sector rotation trends in the fund's holdings.
| Sector | 31 Oct 2026 | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 31.53% | 29.31% | 24.48% | 24.72% | 22.27% | 17.38% |
| Financial | 27.69% | 23.41% | 17.18% | 19.90% | 14.04% | 13.08% |
| Services | 12.37% | 6.17% | 5.39% | 5.03% | 2.09% | 2.24% |
| Automobile | 9.45% | 15.33% | 8.87% | 3.36% | 5.72% | 5.77% |
| Metals & Mining | 6.27% | 6.31% | 8.80% | 7.37% | 20.19% | 19.18% |
| Energy | 3.13% | - | - | - | 3.13% | 9.53% |
| Consumer Staples | 3.04% | 3.21% | 8.42% | 8.97% | 5.27% | 5.09% |
| Technology | 2.95% | 0.43% | 3.12% | 2.93% | - | - |
| Consumer Discretionary | 2.87% | 6.57% | 7.25% | 7.03% | 2.86% | 2.92% |
| Chemicals | - | 2.77% | 2.61% | 6.14% | 2.54% | - |
| Materials | - | 2.51% | 2.67% | - | 3.14% | 3.37% |
| Capital Goods | - | - | 10.07% | 10.61% | 11.66% | 10.99% |
| Construction | - | - | - | 2.70% | - | - |
| Communication | - | - | - | - | - | 2.37% |
Equity Insights
A detailed look at the equity holdings of this scheme — aggregated scores on value, momentum, quality parameters along with diversification and performance analysis.
Style Analysis
Value score
36.5 / 100
Weighted average Value score is 36.5. This indicates that portfolio is relatively reasonably valued using composite of value measures.
Price Momentum score
72.1 / 100
Weighted average Price Momentum score is 72.1. This indicates that portfolio has average momentum using composite of momentum measures.
Quality score
69.2 / 100
Weighted average Quality score is 69.2. This indicates that portfolio has average quality using composite of quality measures.
QVM score
65.1 / 100
Weighted average QVM score is 65.1. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
Red Flags
Frequently Asked Questions
What are the top holdings of Capitalmind Flexi Cap Fund Direct-Growth?
The top holdings of Capitalmind Flexi Cap Fund Direct-Growth as of 31 Oct 2026 are Laurus Labs Ltd. (5.34%), Bank of Maharashtra (4.18%), Divis Laboratories Ltd. (4.08%), Karur Vysya Bank Ltd. (4.03%), The Federal Bank Ltd. (3.98%). These top 5 stocks together account for 21.61% of the total portfolio. You can view the complete holdings breakdown above.
How many stocks does Capitalmind Flexi Cap Fund Direct-Growth hold in its portfolio?
Capitalmind Flexi Cap Fund Direct-Growth holds 32 stocks in its portfolio as of 31 Oct 2026. The fund's portfolio size reflects the fund manager's investment approach, a more concentrated portfolio indicates higher conviction bets, while a larger number of holdings suggests a more diversified strategy.
What is the sector allocation of Capitalmind Flexi Cap Fund Direct-Growth?
As of 31 Oct 2026, Capitalmind Flexi Cap Fund Direct-Growth's top sector allocations are Healthcare (31.53%), Financial (27.69%), Services (12.37%). You can find detailed sector allocation above.
What is the equity and debt allocation of Capitalmind Flexi Cap Fund Direct-Growth?
As of 31 Oct 2026, Capitalmind Flexi Cap Fund Direct-Growth has 99.30% allocated to equity, and 1.00% to debt. You can also check the historical trends above.
What is the market cap allocation of Capitalmind Flexi Cap Fund Direct-Growth?
As of 31 Oct 2026, Capitalmind Flexi Cap Fund Direct-Growth's market cap allocation is 13.19% in large caps, 42.27% in mid caps, and 44.54% in small caps.
What is the PE ratio of Capitalmind Flexi Cap Fund Direct-Growth's portfolio?
The portfolio PE ratio of Capitalmind Flexi Cap Fund Direct-Growth is 22.54 as of 31 Oct 2026. The portfolio PE ratio tells you how expensive or cheap the fund's holdings are relative to their earnings.
What is the credit quality of Capitalmind Flexi Cap Fund Direct-Growth?
A credit rating breakdown is not available for Capitalmind Flexi Cap Fund Direct-Growth — its non-equity allocation was 1.00% as of the latest disclosure. This is common when a fund's non-equity holdings are mostly cash or short-term money market instruments, which aren't assigned a credit rating the way bonds are.
When is the latest portfolio disclosure for Capitalmind Flexi Cap Fund Direct-Growth?
The latest portfolio disclosure for Capitalmind Flexi Cap Fund Direct-Growth is as of 31 Oct 2026. SEBI requires all mutual funds to disclose their complete portfolio holdings on a monthly basis, typically within 10 days of the end of each month.